Summary
JATT Chart
JATT II Acquisition Corp Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Farallon Capital Farallon Capital Management LLC | 300,000 | $3.41M | $3.41M | - | - |
| BO Brian Oliveira Clear Street Group Inc. | 7,123 | $80,917 | $80,917 | - | - |
| KJ Ken Joseph Braidwel LLP | 250,000 | $2.84M | $2.84M | - | - |
 Zachary Canonico DIADEMA PARTNERS LP | 9,021 | $102,479 | $102,479 | - | - |
 Yuen Man Lee Persistent Asset Partners Ltd. | 2,300 | $26,128 | $26,128 | - | - |
JATT II Acquisition Corp (JATT) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
JATT II Acquisition Corp Profile
| Trading Companies & Distributors Industry | Industrials Sector | Someit Sidhu CEO | NASDAQ (NMS) Exchange | G50752107 CUSIP |
| KY Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
JATT Acquisition Corp is a newly incorporated entity, founded in 2021 and headquartered in Grand Cayman, Cayman Islands. The company currently does not engage in significant operational activities but is focused on performing strategic business combinations. Specifically, JATT Acquisition Corp aims to pursue a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The primary focus of their investment strategy is on companies operating in the life sciences sector, highlighting their commitment to advancing health and biotechnology initiatives.
Products and Services
- Merger Facilitation
JATT Acquisition Corp seeks to engage in mergers with businesses that have demonstrated potential or existing strength in the life sciences field, thereby integrating operations and resources to drive growth and innovation.
- Capital Share Exchange
The company aims to offer capital share exchanges, allowing investors and stakeholders from partner organizations to exchange shares for increased equity and benefits, creating a larger synergistic entity in the life sciences market.
- Asset Acquisition
Through targeted asset acquisition, JATT Acquisition Corp intends to purchase significant assets from companies in the life sciences sector, fostering growth opportunities and enhancing its operational capabilities.
- Share Purchase Transactions
JATT Acquisition Corp plans to execute share purchase transactions, which would facilitate individual and institutional investors in acquiring shares from life sciences enterprises, thus bolstering market presence and shareholder value.
- Reorganization Strategies
The company is committed to reorganization strategies for partnering organizations, aiming to optimize operational structures, enhance efficiencies, and leverage synergies to improve overall performance in the life sciences domain.
- Strategic Business Combinations
JATT Acquisition Corp plans to conduct various forms of business combination strategies designed to capture emergent opportunities in the life sciences sector, ensuring higher returns for investors and contributing positively to health advancements.
